Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Avadel Pharmaceuticals Plc (AVDL)

6.76   0 (0%) 01-21 00:51
Open: 6.85 Pre. Close: 6.76
High: 6.91 Low: 6.67
Volume: 167,474 Market Cap: 394M
Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. It also markets three sterile injectable drugs used in the hospital setting, including Akovaz that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia; Bloxiverz, a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery; and Vazculep, a phenylephrine hydrochloride injection indicated for the treatment of clinically important hypotension. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.917 - 6.957 6.957 - 6.993
Low: 6.58 - 6.623 6.623 - 6.661
Close: 6.698 - 6.767 6.767 - 6.829

Technical analysis

as of: 2021-01-20 4:44:38 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 8.73     One year: 9.58
Support: Support1: 6.29    Support2: 5.23
Resistance: Resistance1: 7.47    Resistance2: 8.20
Pivot: 6.69
Moving Average: MA(5): 6.70     MA(20): 6.74
MA(100): 6.22     MA(250): 7.48
MACD: MACD(12,26): -0.03     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 57.78     %D(3): 48.47
RSI: RSI(14): 49.54
52-week: High: 13.49  Low: 4.00  Change(%): -10.2
Average Vol(K): 3-Month: 46873  10-Days: 31004

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
AVDL has closed below upper band by 36.5%. Bollinger Bands are 67.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to AVDL's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 14 Jan 2021
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of "Buy" by Brokerages - MarketBeat

Sun, 10 Jan 2021
Avadel Pharmaceuticals' (NASDAQ:AVDL) Stock Price Has Reduced 35% In The Past Three Years - Simply Wall St

Tue, 22 Dec 2020
Zacks: Analysts Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) Will Post Earnings of -$0.28 Per Share - MarketBeat

Wed, 16 Dec 2020
Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA - GlobeNewswire

Mon, 23 Nov 2020
Avadel Pharmaceuticals to Present at Upcoming December 2020 Investor Conferences - GlobeNewswire

Wed, 11 Nov 2020
Avadel Pharmaceuticals to Present at Upcoming November 2020 Investor Conferences - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 58
Shares Float (M) 42
% Held by Insiders 5.89
% Held by Institutions 56.94
Shares Short (K) 4,110
Shares Short P. Month (K) 4,290

Stock Financials

EPS 0.320
EPS Est This Year 1.160
EPS Est Next Year 0.250
Book Value (p.s.) 2.940
Profit Margin 46.71
Operating Margin -88.35
Return on Assets (ttm) -7.6
Return on Equity (ttm) 21.6
Qtrly Rev. Growth
Gross Profit (p.s.) 0.808
Sales Per Share 0.572
EBITDA (p.s.) -0.469
Qtrly Earnings Growth
Operating Cash Flow (M) -38
Levered Free Cash Flow (M) -56

Stock Valuations

PE Ratio 21.13
PEG Ratio
Price to Book value 2.30
Price to Sales 11.82
Price to Cash Flow -10.40

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.